All Journals > Clinical Infectious Diseases > 1 April 2007 > Naturally Acquired Inhalation Anthrax

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

CID LISTED AMONG
“MOST INFLUENTIAL”

Clinical Infectious Diseases has been named as one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. The list was compiled by the 680-plus members of SLA’s Biomedical and Life Sciences Division.

See the full list here.

Source: The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

In the News

Featured in MSNBC
"Germs and flu are up; infection control is down" June 9, 2009
Trends in the Incidence of Methicillin‐Resistant Staphylococcus aureus Infection in Children’s Hospitals in the United States
Jeffrey S. Gerber, Susan E. Coffin, Sarah A. Smathers, and Theoklis E. Zaoutis
Just this week, researchers reported that the incidence of MRSA infections among children admitted to pediatric hospitals in the United States more than tripled between 2002 and 2007. Researchers at the Children’s Hospital of Philadelphia and the University of Pennsylvania found cases of MRSA jumped from 6.7 per 1,000 admissions in 2002 to 21.1 cases per 1,000 admissions in 2007, according to a study released online Monday in the journal Clinical Infectious Diseases.

Featured in Toronto Star
"Pigs, viruses and politics" May 2, 2009
Are Swine Workers in the United States at Increased Risk of Infection with Zoonotic Influenza Virus?
Kendall P. Myers, Christopher W. Olsen, Sharon F. Setterquist, Ana W. Capuano, Kelley J. Donham, Eileen L. Thacker, James A. Merchant, and Gregory C. Gray
Another study, this one published in the U.S. journal Clinical Infectious Diseases in 2006, found that workers in meat-processing plants have a greater likelihood of being infected by some version of the H1N1 flu virus than the general population (the odds of pig farmers getting the disease are significantly greater again).

Featured in Philadelphia Inquirer
"A shot in the arm for vaccines" April 19, 2009
Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
Lisa A. Jackson and Edward N. Janoff
Every year, an estimated 915,000 people 65 and older get pneumonia, and 40 percent of them end up in hospitals, according to a 2004 paper in the journal Clinical Infectious Diseases. Pneumonia often kills older people, said Richard Stefanacci, a geriatrician at the University of the Sciences in Philadelphia.

1 April 2007

Volume 44, Number 7
Clinical Infectious Diseases 2007;44:968–971
1058-4838/2007/4407-0014$15.00
DOI: 10.1086/512372
BRIEF REPORT

A Case of Naturally Acquired Inhalation Anthrax: Clinical Care and Analyses of Anti–Protective Antigen Immunoglobulin G and Lethal Factor

James J. Walsh,1

Nicki Pesik,3

Conrad P. Quinn,4

Veronica Urdaneta,2

Clare A. Dykewicz,4

Anne E. Boyer,7

Jeannette Guarner,5

Patricia Wilkins,4

Kim J. Norville,1

John R. Barr,7

Sherif R. Zaki,5

Jean B. Patel,6

Sarah P. Reagan,4

James L. Pirkle,7

Tracee A. Treadwell,3

Nancy Rosenstein Messonnier,4

Lisa D. Rotz,3

Richard F. Meyer,3 and

David S. Stephens8

1Section of Pulmonary and Critical Care Medicine, Guthrie Clinic, Sayre, and 2Division of Infectious Disease Epidemiology, Pennsylvania Department of Health, Harrisburg, Pennsylvania; and 3Bioterrorism Preparedness and Response Program and Divisions of 4Bacterial and Mycotic Diseases, 5Viral and Rickettsial Diseases, and 6Healthcare Quality Promotion, National Center for Infectious Diseases, Coordinating Center for Infectious Diseases, and 7Division of Laboratory Sciences, National Center for Environmental Health, Coordinating Center for Environmental Health and Injury Prevention, Centers for Disease Control and Prevention, and 8Emory University School of Medicine, Atlanta, Georgia

This report describes the first case of naturally acquired inhalation anthrax in the United States since 1976. The patient’s clinical course included adjunctive treatment with human anthrax immunoglobulin. Clinical correlation of serologic assays for the lethal factor component of lethal toxin and anti–protective antigen immunoglobulin G are also presented.

Received 29 September 2006; accepted 14 December 2006; electronically published 26 February 2007.

Reprints or correspondence: Dr. Nicki Pesik, Bioterrorism Preparedness and Response Program, Centers for Disease Control and Prevention, 1600 Clifton Rd., NE, Mailstop C‐18, Atlanta, GA 30333 ().

Cited by

Christian A. Schmittinger, Martin W. Dünser, Ganbat Tsenddorj. (2009) Norepinephrine in anthrax-associated shock: Even worse than figs?*. Critical Care Medicine 37:4, 1510-1513
Online publication date: 1-May-2009.
CrossRef
Nicholas J. Vietri, Bret K. Purcell, Steven A. Tobery, Suzanne L. Rasmussen, Elizabeth K. Leffel, Nancy A. Twenhafel, Bruce E. Ivins, Mark D. Kellogg, Wendy M. Webster, Mary E. Wright, and Arthur M. Friedlander. (2009) A Short Course of Antibiotic Treatment Is Effective in Preventing Death from Experimental Inhalational Anthrax after Discontinuing Antibiotics. The Journal of Infectious Diseases 199:3, 336-341
Online publication date: 1-Feb-2009.
Sean V. Shadomy, Theresa L. Smith. (2008) Anthrax. Journal of the American Veterinary Medical Association 233:1, 63-72
Online publication date: 1-Aug-2008.
CrossRef
John D. Grabenstein. (2008) Vaccines: Countering Anthrax: Vaccines and Immunoglobulins. Clinical Infectious Diseases 46:1, 129-136
Online publication date: 1-Jan-2008.
Yan Li, Kevin Sherer, Xizhong Cui, Peter Q Eichacker. (2007) New insights into the pathogenesis and treatment of anthrax toxin-induced shock. Expert Opinion on Biological Therapy 7:6, 843-854
Online publication date: 1-Jul-2007.
CrossRef
Close Popup